Close Menu

NEW YORK – Genedrive announced on Monday that it has entered a distribution agreement with Beckman Coulter Life Sciences to sell and distribute Genedrive's SARS-CoV-2 kit. 

Under the agreement, Danaher subsidiary Beckman Coulter will sell and distribute Genedrive's 96 SARS-CoV-2 test in the US and Europe for use on upper respiratory viral samples. The companies are planning to launch the test commercially in mid-February, Genedrive said in a statement.

Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.